Nevro Corp., was founded in 2006 ... Yes, we’ve made enormous strides—waveforms have advanced, remote programming is here, and IPGs are smaller with improved battery life and longevity. But none of ...

Scavilla announced the acquisition of Nevro Corporation for $250 million, aimed at expanding Globus' reach into the $2 billion neuromodulation market. He stated, "Nevro technology offers ...

The company made another M&A play this month with its planned acquisition of spinal cord stimulation (SCS) company Nevro. “I’m proud of our team at Globus Medical, delivering incredible ...

Nevro has a beta of 0.91 ... HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion ...

Remote and hybrid working have become the new normal and the desire of many employees being asked to return to the office, but productivity can take a hit unless the right remote setup is in place.

Shares of NYSE NVRO opened at $5.72 on Tuesday. The company has a fifty day moving average price of $4.48 and a 200 day moving average price of $4.98. The firm has a market cap of $214.14 million ...

On February 7, 2025, Nevro Corp was acquired by Globus Medical (NYSE:GMED) in an all-cash transaction valuing NVRO at $5.85 per share, representing a total equity value of approximately $250 million.

Nevro Corp (NYSE:NVRO), a medical device company specializing in spinal cord stimulation (SCS) technology for chronic pain treatment, has recently undergone significant changes in its market ...

On February 7, 2025, Nevro Corp was acquired by Globus Medical (NYSE:GMED) in an all-cash transaction valuing NVRO at $5.85 per share, representing a total equity value of approximately $250 million.